NEW YORK, NY / ACCESSWIRE / March 27, 2018 / MRI Interventions, Inc. (OTCQB: MRIC), today announced that Joe Burnett, CEO, will present at the MicroCap Conference on April 9th and 10th at the Essex House in New York City.

The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors. To request free registration, please go to the conference website (www.microcapconf.com) and click the "Registration" button. To schedule a one on one meeting with MRI Interventions, please use the MicoCap Conference site, or contact Matt Kreps of Darrow Associates at mkreps@darrowir.com.

News Compliments of ACCESSWIRE.

About MRI Interventions, Inc.

Building on the imaging power of magnetic resonance imaging ("MRI"), MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The ClearPoint Neuro Navigation System, which has received 510(k) clearance and is CE marked, utilizes a hospital's existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.

Forward-Looking Statements

Statements herein concerning MRI Interventions, Inc. (the "Company") plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company's future events, developments, and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company's actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: future revenues from sales of the Company's ClearPoint Neuro Navigation System products; and the Company's ability to market, commercialize and achieve broader market acceptance for the Company's ClearPoint Neuro Navigation System products. More detailed information on these and additional factors that could affect the Company's actual results are described in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2017 which has been filed with the Securities and Exchange Commission.

Contact Information:

Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

Tony Yu, CEO
MicoCap Conference
tony@microcapconf.com
www.microcapconf.com

SOURCE: MRI Interventions, Inc.